Ownership history in ROYCE & ASSOCIATES LP · 38 quarters on record
This page tracks every 13F SEC filing in which ROYCE & ASSOCIATES LP reported a position in INOGEN INC (INGN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 549,470 | -51,498 | -8.6% | 0.04% | $3.7M | $6.72 |
| 2025 Q3 | ADDED | 600,968 | +79,238 | +15.2% | 0.05% | $4.9M | $8.17 |
| 2025 Q2 | ADDED | 521,730 | +77,273 | +17.4% | 0.04% | $3.7M | $7.03 |
| 2025 Q1 | ADDED | 444,457 | +133,258 | +42.8% | 0.03% | $3.2M | $7.13 |
| 2024 Q4 | ADDED | 311,199 | +259,308 | +499.7% | 0.03% | $2.9M | $9.17 |
| 2024 Q3 | ADDED | 51,891 | +32,482 | +167.4% | 0.00% | $503K | $9.70 |
| 2024 Q2 | REDUCED | 19,409 | -49,862 | -72.0% | 0.00% | $158K | $8.13 |
| 2024 Q1 | ADDED | 69,271 | +64,518 | +1357.4% | 0.00% | $559K | $8.07 |
| 2021 Q3 | REDUCED | 4,753 | -3,557 | -42.8% | 0.00% | $205K | $43.09 |
| 2021 Q2 | REDUCED | 8,310 | -931 | -10.1% | 0.00% | $542K | $65.17 |
As of 2025 Q4 — sorted by position size